Global Immunotherapy Drugs Market

Global Immunotherapy Drugs Market Segment Analysis

Based on the type, market is segmented into monoclonal antibodies, immunomodulators, interlukins, vaccines. The monoclonal antibodies segment account for the maximum share of market revenue due to its improved implementation in cancer immunotherapy. It frequently has fewer side effects than other cancer treatments and helps the immune system fight cancer. Revenue growth in this market is being driven by immunomodulators' notable accuracy in preventing cancer when compared to other techniques. These are substances that either stimulate newly developed immune responses or boost already existing ones in order to identify and eradicate cancer cells.

Based on the therapy area, market is segmented into cancer, autoimmune disease, inflammatory disease, infectious disease. Cancer treatment accounted for largest use of immunotherapy drugs. One of the main factors influencing this segment's revenue growth is the rising incidence of cancer around the world, which is being accompanied by a shift away from chemotherapy due to its adverse effects. An enormous increase in the quantity of successful R&D (Research and Development) efforts is being caused by the rising prevalence of autoimmune illnesses.

By end user, market is segmented into hospital and clinic. Hospitals account for the major share for the use of immunotherapy drugs.

[caption id="attachment_15054" align="aligncenter" width="1920"] Immunotherapy Drugs Market | Exactitude Consultancy[/caption]

Global Immunotherapy Drugs Market Players

Key competitors from both domestic and international markets compete fiercely in the worldwide global Immunotherapy Drugs industry include Amgen Inc., Novartis AG, AbbVie Inc., Pfizer Inc., Nextera AS, Johnson & Johnson Services Inc., AstraZeneca, GSK, Sanofi, Biomunex Pharmaceuticals. Recent News:

• 20^th March 2022: Nextera AS strategically collaborated with Zelluna Immunotherapy AS for the development of optimized TCRs for cancer immunotherapy.
• February 2022: Biomunex Pharmaceuticals collaborated with Institut Curie to develop an immunotherapy drug candidate to treat hematological malignancies using Biomunex’ BiXAR technology.

Who Should Buy? Or Key stakeholders

• Immunotherapy Drugs Providers
• Research and Development Organizations
• Regulatory Agencies
• Specialties Pharmacy
• Cancer Clinics
• Pharmaceutical Manufactures
• Investors
• Others

Global Immunotherapy Drugs Market Regional Analysis

The Global Immunotherapy Drugs Market by region includes North America, Asia-Pacific (APAC), Europe, South America, and Middle East & Africa (MEA).

• North America: includes the US, Canada, Mexico
• Asia Pacific: includes China, Japan, South Korea, India, Australia, ASEAN and Rest of APAC
• Europe: includes UK, Germany, France, Italy, Spain, Russia, and Rest of Europe
• South America: includes Brazil, Argentina and Rest of South America
• Middle East & Africa: includes Turkey, UAE, Saudi Arabia, South Africa, and Rest of MEA

[caption id="attachment_15055" align="aligncenter" width="1920"] Immunotherapy Drugs Market | Exactitude Consultancy[/caption]

Due to an increase in FDA approvals, North America currently holds a monopoly on the market for immunotherapy medications. Additionally, throughout the projected period, the prevalence of autoimmune disorders and cancer will increase, which will further support the expansion of the market for immunotherapy drugs in the area. Due to the rising costs of building a healthcare infrastructure, the immunotherapy medicine market in Asia-Pacific is expected to grow significantly throughout this period. Furthermore, it is projected that in the upcoming years, the market for immunotherapy medications in the region will rise significantly due to the large patient pool and rising cancer incidence.

Key Market Segments: Global Immunotherapy Drugs Market

Global Immunotherapy Drugs Market By Type, 2020-2029, (USD Billion), (Thousand Units)

• Monoclonal Antibodies
• Immunomodulators
• Interlukins
• Vaccines

Global Immunotherapy Drugs Market By Therapy Area, 2020-2029, (USD Billion), (Thousand Units)

• Cancer
• Autoimmune Disease
• Inflammatory Disease
• Infectious Disease

Global Immunotherapy Drugs Market By End User, 2020-2029, (USD Billion), (Thousand Units)

• Hospital
• Clinic

Global Immunotherapy Drugs Market By Region, 2020-2029, (USD Billion), (Thousand Units)

• North America
• Europe
• Asia Pacific
• South America
• Middle East And Africa

Important Countries In All Regions Are Covered

Exactitude Consultancy Services Key Objectives

• Increasing sales and market share
• Developing new technology
• Improving profitability
• Entering new market
• Enhancing brand reputation

Key Question Answered

• What is the expected growth rate of the immunotherapy drugs market over the next 7 years?
• Who are the major players in the immunotherapy drugs market and what is their market share?
• What are the end-user industries driving demand for market and what is their outlook?
• What are the opportunities for growth in emerging markets such as Asia-Pacific, Middle East, and Africa?
• How is the economic environment affecting the immunotherapy drugs market, including factors such as interest rates, inflation, and exchange rates?
• What is the expected impact of government policies and regulations on the immunotherapy drugs market?
• What is the current and forecasted size and growth rate of the global immunotherapy drugs market?
• What are the key drivers of growth in the immunotherapy drugs market?
• What are the distribution channels and supply chain dynamics in the immunotherapy drugs market?
• What are the technological advancements and innovations in the immunotherapy drugs market and their impact on product development and growth?
• What are the regulatory considerations and their impact on the market?
• What are the challenges faced by players in the immunotherapy drugs market and how are they addressing these challenges?
• What are the opportunities for growth and expansion in the immunotherapy drugs market?
• What are the product offerings and specifications of leading players in the market?
• What is the pricing trend of immunotherapy drugs’ in the market and what is the impact of raw material prices on the price trend?

1. INTRODUCCIÓN
   
   
   
   1. DEFINICIÓN DE MERCADO
   
   
   2. SEGMENTACIÓN DEL MERCADO
   
   
   3. CRONOGRAMAS DE INVESTIGACIÓN
   
   
   4. SUPUESTOS Y LIMITACIONES
   
   
   
   


2. METODOLOGÍA DE LA INVESTIGACIÓN
   
   
   
   1. MINERÍA DE DATOS
      
      
      
      1. INVESTIGACIÓN SECUNDARIA
      
      
      2. INVESTIGACIÓN PRIMARIA
      
      
      3. ASESORAMIENTO DE EXPERTOS EN LA MATERIA
      
      
      
      
   
   
   2. CONTROLES DE CALIDAD
      
      
      
      1. REVISIÓN FINAL
      
      
      
      
   
   
   3. TRIANGULACIÓN DE DATOS
      
      
      
      1. ENFOQUE DE ABAJO HACIA ARRIBA
      
      
      2. ENFOQUE DE ARRIBA HACIA ABAJO
      
      
      3. FLUJO DE INVESTIGACIÓN
      
      
      
      
   
   
   4. FUENTES DE DATOS
   
   
   
   


3. RESUMEN EJECUTIVO


4. PANORAMA DEL MERCADO
   
   
   
   1. PERSPECTIVAS DEL MERCADO MUNDIAL DE FÁRMACOS DE INMUNOTERAPIA
      
      
      
      1. IMPULSORES DEL MERCADO
      
      
      2. RESTRICCIONES DEL MERCADO
      
      
      3. OPORTUNIDADES DE MERCADO
      
      
      
      
   
   
   2. IMPACTO DEL COVID-19 EN EL MERCADO DE MEDICAMENTOS DE INMUNOTERAPIA
   
   
   3. MODELO DE LAS CINCO FUERZAS DE PORTER
      
      
      
      1. AMENAZA DE NUEVOS INGRESANTES
      
      
      2. AMENAZA DE SUSTITUTOS
      
      
      3. PODER DE NEGOCIACIÓN DE LOS PROVEEDORES
      
      
      4. PODER DE NEGOCIACIÓN DE LOS CLIENTES
      
      
      5. GRADO DE COMPETENCIA
      
      
      
      
   
   
   4. ANÁLISIS DE LA CADENA DE VALOR DE LA INDUSTRIA
   
   
   
   


5. MERCADO MUNDIAL DE FÁRMACOS DE INMUNOTERAPIA POR TIPO, 2020-2029, (MIL MILLONES DE USD), (MILES DE UNIDADES)
   
   
   
   1. ANTICUERPOS MONOCLONALES
   
   
   2. INMUNOMODULADORES
   
   
   3. INTERLUKINS
   
   
   4. VACUNAS
   
   
   
   


6. MERCADO MUNDIAL DE FÁRMACOS DE INMUNOTERAPIA POR ÁREA TERAPÉUTICA, 2020-2029, (MILES DE MILLONES DE USD), (MILES DE UNIDADES)
   
   
   
   1. CÁNCER
   
   
   2. ENFERMEDAD AUTOINMUNE
   
   
   3. ENFERMEDAD INFLAMATORIA
   
   
   4. ENFERMEDAD INFECCIOSA
   
   
   
   


7. MERCADO MUNDIAL DE FÁRMACOS DE INMUNOTERAPIA POR USUARIO FINAL, 2020-2029, (MILES DE MILLONES DE USD), (MILES DE UNIDADES)
   
   
   
   1. HOSPITAL
   
   
   2. CLÍNICA
   
   
   
   


8. MERCADO MUNDIAL DE FÁRMACOS DE INMUNOTERAPIA POR REGIÓN, 2020-2029, (MIL MILLONES DE USD), (MILES DE UNIDADES)
   
   
   
   1. AMÉRICA DEL NORTE
      
      
      
      1. A NOSOTROS
      
      
      2. CANADÁ
      
      
      3. MÉXICO
      
      
      
      
   
   
   2. SUDAMERICA
      
      
      
      1. BRASIL
      
      
      2. ARGENTINA
      
      
      3. COLOMBIA
      
      
      4. RESTO DE SUDAMÉRICA
      
      
      
      
   
   
   3. EUROPA
      
      
      
      1. ALEMANIA
      
      
      2. Reino Unido
      
      
      3. FRANCIA
      
      
      4. ITALIA
      
      
      5. ESPAÑA
      
      
      6. RUSIA
      
      
      7. RESTO DE EUROPA
      
      
      
      
   
   
   4. ASIA PACÍFICO
      
      
      
      1. INDIA
      
      
      2. PORCELANA
      
      
      3. JAPÓN
      
      
      4. COREA DEL SUR
      
      
      5. AUSTRALIA
      
      
      6. ASIA SUDESTE
      
      
      7. RESTO DE ASIA PACÍFICO
      
      
      
      
   
   
   5. ORIENTE MEDIO Y ÁFRICA
      
      
      
      1. Emiratos Árabes Unidos
      
      
      2. ARABIA SAUDITA
      
      
      3. SUDÁFRICA
      
      
      4. REST OF MIDDLE EAST AND AFRICA
      
      
      
      
   
   
   
   

    9. COMPANY PROFILES*  (BUSINESS OVERVIEW, COMPANY SNAPSHOT, PRODUCTS OFFERED, RECENT DEVELOPMENTS)

1. AMGEN INC.


2. NOVARTIS AG


3. ABBVIE INC.


4. PFIZER INC.


5. NEXTERA AS


6. JOHNSON & JOHNSON SERVICES INC.


7. ASTRAZENECA


8. GSK


9. SANOFI


10. BIOMUNEX PHARMACEUTICALS *THE COMPANY LIST IS INDICATIVE

LIST OF TABLES

TABLE 1 GLOBAL IMMUNOTHERAPY DRUGS MARKET BY TYPE (USD BILLION) 2020-2029

TABLE 2 GLOBAL IMMUNOTHERAPY DRUGS MARKET BY TYPE (THOUSAND UNITS) 2020-2029

TABLE 3 GLOBAL IMMUNOTHERAPY DRUGS MARKET BY THERAPY AREA (USD BILLION) 2020-2029

TABLE 4 GLOBAL IMMUNOTHERAPY DRUGS MARKET BY THERAPY AREA (THOUSAND UNITS) 2020-2029

TABLE 5 GLOBAL IMMUNOTHERAPY DRUGS MARKET BY END USER (USD BILLION) 2020-2029

TABLE 6 GLOBAL IMMUNOTHERAPY DRUGS MARKET BY END USER (THOUSAND UNITS) 2020-2029

TABLE 7 GLOBAL IMMUNOTHERAPY DRUGS MARKET BY REGION (USD BILLION) 2020-2029

TABLE 8 GLOBAL IMMUNOTHERAPY DRUGS MARKET BY REGION (THOUSAND UNITS) 2020-2029

TABLE 9 NORTH AMERICA IMMUNOTHERAPY DRUGS MARKET BY COUNTRY (USD BILLION) 2020-2029

TABLE 10 NORTH AMERICA IMMUNOTHERAPY DRUGS MARKET BY COUNTRY (THOUSAND UNITS) 2020-2029

TABLE 11 NORTH AMERICA IMMUNOTHERAPY DRUGS MARKET BY TYPE (USD BILLION) 2020-2029

TABLE 12 NORTH AMERICA IMMUNOTHERAPY DRUGS MARKET BY TYPE (THOUSAND UNITS) 2020-2029

TABLE 13 NORTH AMERICA IMMUNOTHERAPY DRUGS MARKET BY THERAPY AREA (USD BILLION) 2020-2029

TABLE 14 NORTH AMERICA IMMUNOTHERAPY DRUGS MARKET BY THERAPY AREA (THOUSAND UNITS) 2020-2029

TABLE 15 NORTH AMERICA IMMUNOTHERAPY DRUGS MARKET BY END USER (USD BILLION) 2020-2029

TABLE 16 NORTH AMERICA IMMUNOTHERAPY DRUGS MARKET BY END USER (THOUSAND UNITS) 2020-2029

TABLE 17 US IMMUNOTHERAPY DRUGS MARKET BY TYPE (USD BILLION) 2020-2029

TABLE 18 US IMMUNOTHERAPY DRUGS MARKET BY TYPE (THOUSAND UNITS) 2020-2029

TABLE 19 US IMMUNOTHERAPY DRUGS MARKET BY THERAPY AREA (USD BILLION) 2020-2029

TABLE 20 US IMMUNOTHERAPY DRUGS MARKET BY THERAPY AREA (THOUSAND UNITS) 2020-2029

TABLE 21 US IMMUNOTHERAPY DRUGS MARKET BY END USER (USD BILLION) 2020-2029

TABLE 22 US IMMUNOTHERAPY DRUGS MARKET BY END USER (THOUSAND UNITS) 2020-2029

TABLE 23 CANADA IMMUNOTHERAPY DRUGS MARKET BY TYPE (USD BILLION) 2020-2029

TABLE 24 CANADA IMMUNOTHERAPY DRUGS MARKET BY TYPE (THOUSAND UNITS) 2020-2029

TABLE 25 CANADA IMMUNOTHERAPY DRUGS MARKET BY THERAPY AREA (USD BILLION) 2020-2029

TABLE 26 CANADA IMMUNOTHERAPY DRUGS MARKET BY THERAPY AREA (THOUSAND UNITS) 2020-2029

TABLE 27 CANADA IMMUNOTHERAPY DRUGS MARKET BY END USER (USD BILLION) 2020-2029

TABLE 28 CANADA IMMUNOTHERAPY DRUGS MARKET BY END USER (THOUSAND UNITS) 2020-2029

TABLE 29 MEXICO IMMUNOTHERAPY DRUGS MARKET BY TYPE (USD BILLION) 2020-2029

TABLE 30 MEXICO IMMUNOTHERAPY DRUGS MARKET BY TYPE (THOUSAND UNITS) 2020-2029

TABLE 31 MEXICO IMMUNOTHERAPY DRUGS MARKET BY THERAPY AREA (USD BILLION) 2020-2029

TABLE 32 MEXICO IMMUNOTHERAPY DRUGS MARKET BY THERAPY AREA (THOUSAND UNITS) 2020-2029

TABLE 33 MEXICO IMMUNOTHERAPY DRUGS MARKET BY END USER (USD BILLION) 2020-2029

TABLE 34 MEXICO IMMUNOTHERAPY DRUGS MARKET BY END USER (THOUSAND UNITS) 2020-2029

TABLE 35 SOUTH AMERICA IMMUNOTHERAPY DRUGS MARKET BY COUNTRY (USD BILLION) 2020-2029

TABLE 36 SOUTH AMERICA IMMUNOTHERAPY DRUGS MARKET BY COUNTRY (THOUSAND UNITS) 2020-2029

TABLE 37 SOUTH AMERICA IMMUNOTHERAPY DRUGS MARKET BY TYPE (USD BILLION) 2020-2029

TABLE 38 SOUTH AMERICA IMMUNOTHERAPY DRUGS MARKET BY TYPE (THOUSAND UNITS) 2020-2029

TABLE 39 SOUTH AMERICA IMMUNOTHERAPY DRUGS MARKET BY THERAPY AREA (USD BILLION) 2020-2029

TABLE 40 SOUTH AMERICA IMMUNOTHERAPY DRUGS MARKET BY THERAPY AREA (THOUSAND UNITS) 2020-2029

TABLE 41 SOUTH AMERICA IMMUNOTHERAPY DRUGS MARKET BY END USER (USD BILLION) 2020-2029

TABLE 42 SOUTH AMERICA IMMUNOTHERAPY DRUGS MARKET BY END USER (THOUSAND UNITS) 2020-2029

TABLE 43 BRAZIL IMMUNOTHERAPY DRUGS MARKET BY TYPE (USD BILLION) 2020-2029

TABLE 44 BRAZIL IMMUNOTHERAPY DRUGS MARKET BY TYPE (THOUSAND UNITS) 2020-2029

TABLE 45 BRAZIL IMMUNOTHERAPY DRUGS MARKET BY THERAPY AREA (USD BILLION) 2020-2029

TABLE 46 BRAZIL IMMUNOTHERAPY DRUGS MARKET BY THERAPY AREA (THOUSAND UNITS) 2020-2029

TABLE 47 BRAZIL IMMUNOTHERAPY DRUGS MARKET BY END USER (USD BILLION) 2020-2029

TABLE 48 BRAZIL IMMUNOTHERAPY DRUGS MARKET BY END USER (THOUSAND UNITS) 2020-2029

TABLE 49 ARGENTINA IMMUNOTHERAPY DRUGS MARKET BY TYPE (USD BILLION) 2020-2029

TABLE 50 ARGENTINA IMMUNOTHERAPY DRUGS MARKET BY TYPE (THOUSAND UNITS) 2020-2029

TABLE 51 ARGENTINA IMMUNOTHERAPY DRUGS MARKET BY THERAPY AREA (USD BILLION) 2020-2029

TABLE 52 ARGENTINA IMMUNOTHERAPY DRUGS MARKET BY THERAPY AREA (THOUSAND UNITS) 2020-2029

TABLE 53 ARGENTINA IMMUNOTHERAPY DRUGS MARKET BY END USER (USD BILLION) 2020-2029

TABLE 54 ARGENTINA IMMUNOTHERAPY DRUGS MARKET BY END USER (THOUSAND UNITS) 2020-2029

TABLE 55 COLOMBIA IMMUNOTHERAPY DRUGS MARKET BY TYPE (USD BILLION) 2020-2029

TABLE 56 COLOMBIA IMMUNOTHERAPY DRUGS MARKET BY TYPE (THOUSAND UNITS) 2020-2029

TABLE 57 COLOMBIA IMMUNOTHERAPY DRUGS MARKET BY THERAPY AREA (USD BILLION) 2020-2029

TABLE 58 COLOMBIA IMMUNOTHERAPY DRUGS MARKET BY THERAPY AREA (THOUSAND UNITS) 2020-2029

TABLE 59 COLOMBIA IMMUNOTHERAPY DRUGS MARKET BY END USER (USD BILLION) 2020-2029

TABLE 60 COLOMBIA IMMUNOTHERAPY DRUGS MARKET BY END USER (THOUSAND UNITS) 2020-2029

TABLE 61 REST OF SOUTH AMERICA IMMUNOTHERAPY DRUGS MARKET BY TYPE (USD BILLION) 2020-2029

TABLE 62 REST OF SOUTH AMERICA IMMUNOTHERAPY DRUGS MARKET BY TYPE (THOUSAND UNITS) 2020-2029

TABLE 63 REST OF SOUTH AMERICA IMMUNOTHERAPY DRUGS MARKET BY THERAPY AREA (USD BILLION) 2020-2029

TABLE 64 REST OF SOUTH AMERICA IMMUNOTHERAPY DRUGS MARKET BY THERAPY AREA (THOUSAND UNITS) 2020-2029

TABLE 65 REST OF SOUTH AMERICA IMMUNOTHERAPY DRUGS MARKET BY END USER (USD BILLION) 2020-2029

TABLE 66 REST OF SOUTH AMERICA IMMUNOTHERAPY DRUGS MARKET BY END USER (THOUSAND UNITS) 2020-2029

TABLE 67 ASIA-PACIFIC IMMUNOTHERAPY DRUGS MARKET BY COUNTRY (USD BILLION) 2020-2029

TABLE 68 ASIA-PACIFIC IMMUNOTHERAPY DRUGS MARKET BY COUNTRY (THOUSAND UNITS) 2020-2029

TABLE 69 ASIA-PACIFIC IMMUNOTHERAPY DRUGS MARKET BY TYPE (USD BILLION) 2020-2029

TABLE 70 ASIA-PACIFIC IMMUNOTHERAPY DRUGS MARKET BY TYPE (THOUSAND UNITS) 2020-2029

TABLE 71 ASIA-PACIFIC IMMUNOTHERAPY DRUGS MARKET BY THERAPY AREA (USD BILLION) 2020-2029

TABLE 72 ASIA-PACIFIC IMMUNOTHERAPY DRUGS MARKET BY THERAPY AREA (THOUSAND UNITS) 2020-2029

TABLE 73 ASIA-PACIFIC IMMUNOTHERAPY DRUGS MARKET BY END USER (USD BILLION) 2020-2029

TABLE 74 ASIA-PACIFIC IMMUNOTHERAPY DRUGS MARKET BY END USER (THOUSAND UNITS) 2020-2029

TABLE 75 INDIA IMMUNOTHERAPY DRUGS MARKET BY TYPE (USD BILLION) 2020-2029

TABLE 76 INDIA IMMUNOTHERAPY DRUGS MARKET BY TYPE (THOUSAND UNITS) 2020-2029

TABLE 77 INDIA IMMUNOTHERAPY DRUGS MARKET BY THERAPY AREA (USD BILLION) 2020-2029

TABLE 78 INDIA IMMUNOTHERAPY DRUGS MARKET BY THERAPY AREA (THOUSAND UNITS) 2020-2029

TABLE 79 INDIA IMMUNOTHERAPY DRUGS MARKET BY END USER (USD BILLION) 2020-2029

TABLE 80 INDIA IMMUNOTHERAPY DRUGS MARKET BY END USER (THOUSAND UNITS) 2020-2029

TABLE 81 CHINA IMMUNOTHERAPY DRUGS MARKET BY TYPE (USD BILLION) 2020-2029

TABLE 82 CHINA IMMUNOTHERAPY DRUGS MARKET BY TYPE (THOUSAND UNITS) 2020-2029

TABLE 83 CHINA IMMUNOTHERAPY DRUGS MARKET BY THERAPY AREA (USD BILLION) 2020-2029

TABLE 84 CHINA IMMUNOTHERAPY DRUGS MARKET BY THERAPY AREA (THOUSAND UNITS) 2020-2029

TABLE 85 CHINA IMMUNOTHERAPY DRUGS MARKET BY END USER (USD BILLION) 2020-2029

TABLE 86 CHINA IMMUNOTHERAPY DRUGS MARKET BY END USER (THOUSAND UNITS) 2020-2029

TABLE 87 JAPAN IMMUNOTHERAPY DRUGS MARKET BY TYPE (USD BILLION) 2020-2029

TABLE 88 JAPAN IMMUNOTHERAPY DRUGS MARKET BY TYPE (THOUSAND UNITS) 2020-2029

TABLE 89 JAPAN IMMUNOTHERAPY DRUGS MARKET BY THERAPY AREA (USD BILLION) 2020-2029

TABLE 90 JAPAN IMMUNOTHERAPY DRUGS MARKET BY THERAPY AREA (THOUSAND UNITS) 2020-2029

TABLE 91 JAPAN IMMUNOTHERAPY DRUGS MARKET BY END USER (USD BILLION) 2020-2029

TABLE 92 JAPAN IMMUNOTHERAPY DRUGS MARKET BY END USER (THOUSAND UNITS) 2020-2029

TABLE 93 SOUTH KOREA IMMUNOTHERAPY DRUGS MARKET BY TYPE (USD BILLION) 2020-2029

TABLE 94 SOUTH KOREA IMMUNOTHERAPY DRUGS MARKET BY TYPE (THOUSAND UNITS) 2020-2029

TABLE 95 SOUTH KOREA IMMUNOTHERAPY DRUGS MARKET BY THERAPY AREA (USD BILLION) 2020-2029

TABLE 96 SOUTH KOREA IMMUNOTHERAPY DRUGS MARKET BY THERAPY AREA (THOUSAND UNITS) 2020-2029

TABLE 97 SOUTH KOREA IMMUNOTHERAPY DRUGS MARKET BY END USER (USD BILLION) 2020-2029

TABLE 98 SOUTH KOREA IMMUNOTHERAPY DRUGS MARKET BY END USER (THOUSAND UNITS) 2020-2029

TABLE 99 AUSTRALIA IMMUNOTHERAPY DRUGS MARKET BY TYPE (USD BILLION) 2020-2029

TABLE 100 AUSTRALIA IMMUNOTHERAPY DRUGS MARKET BY TYPE (THOUSAND UNITS) 2020-2029

TABLE 101 AUSTRALIA IMMUNOTHERAPY DRUGS MARKET BY THERAPY AREA (USD BILLION) 2020-2029

TABLE 102 AUSTRALIA IMMUNOTHERAPY DRUGS MARKET BY THERAPY AREA (THOUSAND UNITS) 2020-2029

TABLE 103 AUSTRALIA IMMUNOTHERAPY DRUGS MARKET BY END USER (USD BILLION) 2020-2029

TABLE 104 AUSTRALIA IMMUNOTHERAPY DRUGS MARKET BY END USER (THOUSAND UNITS) 2020-2029

TABLE 105 SOUTH-EAST ASIA IMMUNOTHERAPY DRUGS MARKET BY TYPE (USD BILLION) 2020-2029

TABLE 106 SOUTH-EAST ASIA IMMUNOTHERAPY DRUGS MARKET BY TYPE (THOUSAND UNITS) 2020-2029

TABLE 107 SOUTH-EAST ASIA IMMUNOTHERAPY DRUGS MARKET BY THERAPY AREA (USD BILLION) 2020-2029

TABLE 108 SOUTH-EAST ASIA IMMUNOTHERAPY DRUGS MARKET BY THERAPY AREA (THOUSAND UNITS) 2020-2029

TABLE 109 SOUTH-EAST ASIA IMMUNOTHERAPY DRUGS MARKET BY END USER (USD BILLION) 2020-2029

TABLE 110 SOUTH-EAST ASIA IMMUNOTHERAPY DRUGS MARKET BY END USER (THOUSAND UNITS) 2020-2029

TABLE 111 REST OF ASIA PACIFIC IMMUNOTHERAPY DRUGS MARKET BY TYPE (USD BILLION) 2020-2029

TABLE 112 REST OF ASIA PACIFIC IMMUNOTHERAPY DRUGS MARKET BY TYPE (THOUSAND UNITS) 2020-2029

TABLE 113 REST OF ASIA PACIFIC IMMUNOTHERAPY DRUGS MARKET BY THERAPY AREA (USD BILLION) 2020-2029

TABLE 114 REST OF ASIA PACIFIC IMMUNOTHERAPY DRUGS MARKET BY THERAPY AREA (THOUSAND UNITS) 2020-2029

TABLE 115 REST OF ASIA PACIFIC IMMUNOTHERAPY DRUGS MARKET BY END USER (USD BILLION) 2020-2029

TABLE 116 REST OF ASIA PACIFIC IMMUNOTHERAPY DRUGS MARKET BY END USER (THOUSAND UNITS) 2020-2029

TABLE 117 EUROPE IMMUNOTHERAPY DRUGS MARKET BY COUNTRY (USD BILLION) 2020-2029

TABLE 118 EUROPE IMMUNOTHERAPY DRUGS MARKET BY COUNTRY (THOUSAND UNITS) 2020-2029

TABLE 119 ASIA-PACIFIC IMMUNOTHERAPY DRUGS MARKET BY TYPE (USD BILLION) 2020-2029

TABLE 120 ASIA-PACIFIC IMMUNOTHERAPY DRUGS MARKET BY TYPE (THOUSAND UNITS) 2020-2029

TABLE 121 ASIA-PACIFIC IMMUNOTHERAPY DRUGS MARKET BY THERAPY AREA (USD BILLION) 2020-2029

TABLE 122 ASIA-PACIFIC IMMUNOTHERAPY DRUGS MARKET BY THERAPY AREA (THOUSAND UNITS) 2020-2029

TABLE 123 ASIA-PACIFIC IMMUNOTHERAPY DRUGS MARKET BY END USER (USD BILLION) 2020-2029

TABLE 124 ASIA-PACIFIC IMMUNOTHERAPY DRUGS MARKET BY END USER (THOUSAND UNITS) 2020-2029

TABLE 125 GERMANY IMMUNOTHERAPY DRUGS MARKET BY TYPE (USD BILLION) 2020-2029

TABLE 126 GERMANY IMMUNOTHERAPY DRUGS MARKET BY TYPE (THOUSAND UNITS) 2020-2029

TABLE 127 GERMANY IMMUNOTHERAPY DRUGS MARKET BY THERAPY AREA (USD BILLION) 2020-2029

TABLE 128 GERMANY IMMUNOTHERAPY DRUGS MARKET BY THERAPY AREA (THOUSAND UNITS) 2020-2029

TABLE 129 GERMANY IMMUNOTHERAPY DRUGS MARKET BY END USER (USD BILLION) 2020-2029

TABLE 130 GERMANY IMMUNOTHERAPY DRUGS MARKET BY END USER (THOUSAND UNITS) 2020-2029

TABLE 131 UK IMMUNOTHERAPY DRUGS MARKET BY TYPE (USD BILLION) 2020-2029

TABLE 132 UK IMMUNOTHERAPY DRUGS MARKET BY TYPE (THOUSAND UNITS) 2020-2029

TABLE 133 UK IMMUNOTHERAPY DRUGS MARKET BY THERAPY AREA (USD BILLION) 2020-2029

TABLE 134 UK IMMUNOTHERAPY DRUGS MARKET BY THERAPY AREA (THOUSAND UNITS) 2020-2029

TABLE 135 UK IMMUNOTHERAPY DRUGS MARKET BY END USER (USD BILLION) 2020-2029

TABLE 136 UK IMMUNOTHERAPY DRUGS MARKET BY END USER (THOUSAND UNITS) 2020-2029

TABLE 137 FRANCE IMMUNOTHERAPY DRUGS MARKET BY TYPE (USD BILLION) 2020-2029

TABLE 138 FRANCE IMMUNOTHERAPY DRUGS MARKET BY TYPE (THOUSAND UNITS) 2020-2029

TABLE 139 FRANCE IMMUNOTHERAPY DRUGS MARKET BY THERAPY AREA (USD BILLION) 2020-2029

TABLE 140 FRANCE IMMUNOTHERAPY DRUGS MARKET BY THERAPY AREA (THOUSAND UNITS) 2020-2029

TABLE 141 FRANCE IMMUNOTHERAPY DRUGS MARKET BY END USER (USD BILLION) 2020-2029

TABLE 142 FRANCE IMMUNOTHERAPY DRUGS MARKET BY END USER (THOUSAND UNITS) 2020-2029

TABLE 143 ITALY IMMUNOTHERAPY DRUGS MARKET BY TYPE (USD BILLION) 2020-2029

TABLE 144 ITALY IMMUNOTHERAPY DRUGS MARKET BY TYPE (THOUSAND UNITS) 2020-2029

TABLE 145 ITALY IMMUNOTHERAPY DRUGS MARKET BY THERAPY AREA (USD BILLION) 2020-2029

TABLE 146 ITALY IMMUNOTHERAPY DRUGS MARKET BY THERAPY AREA (THOUSAND UNITS) 2020-2029

TABLE 147 ITALY IMMUNOTHERAPY DRUGS MARKET BY END USER (USD BILLION) 2020-2029

TABLE 148 ITALY IMMUNOTHERAPY DRUGS MARKET BY END USER (THOUSAND UNITS) 2020-2029

TABLE 149 SPAIN IMMUNOTHERAPY DRUGS MARKET BY TYPE (USD BILLION) 2020-2029

TABLE 150 SPAIN IMMUNOTHERAPY DRUGS MARKET BY TYPE (THOUSAND UNITS) 2020-2029

TABLE 151 SPAIN IMMUNOTHERAPY DRUGS MARKET BY THERAPY AREA (USD BILLION) 2020-2029

TABLE 152 SPAIN IMMUNOTHERAPY DRUGS MARKET BY THERAPY AREA (THOUSAND UNITS) 2020-2029

TABLE 153 SPAIN IMMUNOTHERAPY DRUGS MARKET BY END USER (USD BILLION) 2020-2029

TABLE 154 SPAIN IMMUNOTHERAPY DRUGS MARKET BY END USER (THOUSAND UNITS) 2020-2029

TABLE 155 RUSSIA IMMUNOTHERAPY DRUGS MARKET BY TYPE (USD BILLION) 2020-2029

TABLE 156 RUSSIA IMMUNOTHERAPY DRUGS MARKET BY TYPE (THOUSAND UNITS) 2020-2029

TABLE 157 RUSSIA IMMUNOTHERAPY DRUGS MARKET BY THERAPY AREA (USD BILLION) 2020-2029

TABLE 158 RUSSIA IMMUNOTHERAPY DRUGS MARKET BY THERAPY AREA (THOUSAND UNITS) 2020-2029

TABLE 159 RUSSIA IMMUNOTHERAPY DRUGS MARKET BY END USER (USD BILLION) 2020-2029

TABLE 160 RUSSIA IMMUNOTHERAPY DRUGS MARKET BY END USER (THOUSAND UNITS) 2020-2029

TABLE 161 REST OF EUROPE IMMUNOTHERAPY DRUGS MARKET BY TYPE (USD BILLION) 2020-2029

TABLE 162 REST OF EUROPE IMMUNOTHERAPY DRUGS MARKET BY TYPE (THOUSAND UNITS) 2020-2029

TABLE 163 REST OF EUROPE IMMUNOTHERAPY DRUGS MARKET BY THERAPY AREA (USD BILLION) 2020-2029

TABLE 164 REST OF EUROPE IMMUNOTHERAPY DRUGS MARKET BY THERAPY AREA (THOUSAND UNITS) 2020-2029

TABLE 165 REST OF EUROPE IMMUNOTHERAPY DRUGS MARKET BY END USER (USD BILLION) 2020-2029

TABLE 166 REST OF EUROPE IMMUNOTHERAPY DRUGS MARKET BY END USER (THOUSAND UNITS) 2020-2029

TABLE 167 MIDDLE EAST AND AFRICA IMMUNOTHERAPY DRUGS MARKET BY COUNTRY (USD BILLION) 2020-2029

TABLE 168 MIDDLE EAST AND AFRICA IMMUNOTHERAPY DRUGS MARKET BY COUNTRY (THOUSAND UNITS) 2020-2029

TABLE 169 MIDDLE EAST AND AFRICA IMMUNOTHERAPY DRUGS MARKET BY TYPE (USD BILLION) 2020-2029

TABLE 170 MIDDLE EAST AND AFRICA IMMUNOTHERAPY DRUGS MARKET BY TYPE (THOUSAND UNITS) 2020-2029

TABLE 171 MIDDLE EAST AND AFRICA IMMUNOTHERAPY DRUGS MARKET BY THERAPY AREA (USD BILLION) 2020-2029

TABLE 172 MIDDLE EAST AND AFRICA IMMUNOTHERAPY DRUGS MARKET BY THERAPY AREA (THOUSAND UNITS) 2020-2029

TABLE 173 MIDDLE EAST AND AFRICA IMMUNOTHERAPY DRUGS MARKET BY END USER (USD BILLION) 2020-2029

TABLE 174 MIDDLE EAST AND AFRICA IMMUNOTHERAPY DRUGS MARKET BY END USER (THOUSAND UNITS) 2020-2029

TABLE 175 UAE IMMUNOTHERAPY DRUGS MARKET BY TYPE (USD BILLION) 2020-2029

TABLE 176 UAE IMMUNOTHERAPY DRUGS MARKET BY TYPE (THOUSAND UNITS) 2020-2029

TABLE 177 UAE IMMUNOTHERAPY DRUGS MARKET BY THERAPY AREA (USD BILLION) 2020-2029

TABLE 178 UAE IMMUNOTHERAPY DRUGS MARKET BY THERAPY AREA (THOUSAND UNITS) 2020-2029

TABLE 179 UAE IMMUNOTHERAPY DRUGS MARKET BY END USER (USD BILLION) 2020-2029

TABLE 180 UAE IMMUNOTHERAPY DRUGS MARKET BY END USER (THOUSAND UNITS) 2020-2029

TABLE 181 SAUDI ARABIA IMMUNOTHERAPY DRUGS MARKET BY TYPE (USD BILLION) 2020-2029

TABLE 182 SAUDI ARABIA IMMUNOTHERAPY DRUGS MARKET BY TYPE (THOUSAND UNITS) 2020-2029

TABLE 183 SAUDI ARABIA IMMUNOTHERAPY DRUGS MARKET BY THERAPY AREA (USD BILLION) 2020-2029

TABLE 184 SAUDI ARABIA IMMUNOTHERAPY DRUGS MARKET BY THERAPY AREA (THOUSAND UNITS) 2020-2029

TABLE 185 SAUDI ARABIA IMMUNOTHERAPY DRUGS MARKET BY END USER (USD BILLION) 2020-2029

TABLE 186 SAUDI ARABIA IMMUNOTHERAPY DRUGS MARKET BY END USER (THOUSAND UNITS) 2020-2029

TABLE 187 SOUTH AFRICA IMMUNOTHERAPY DRUGS MARKET BY TYPE (USD BILLION) 2020-2029

TABLE 188 SOUTH AFRICA IMMUNOTHERAPY DRUGS MARKET BY TYPE (THOUSAND UNITS) 2020-2029

TABLE 189 SOUTH AFRICA IMMUNOTHERAPY DRUGS MARKET BY THERAPY AREA (USD BILLION) 2020-2029

TABLE 190 SOUTH AFRICA IMMUNOTHERAPY DRUGS MARKET BY THERAPY AREA (THOUSAND UNITS) 2020-2029

TABLE 191 SOUTH AFRICA IMMUNOTHERAPY DRUGS MARKET BY END USER (USD BILLION) 2020-2029

TABLE 192 SOUTH AFRICA IMMUNOTHERAPY DRUGS MARKET BY END USER (THOUSAND UNITS) 2020-2029

TABLE 193 REST OF MIDDLE EAST AND AFRICA IMMUNOTHERAPY DRUGS MARKET BY TYPE (USD BILLION) 2020-2029

TABLE 194 REST OF MIDDLE EAST AND AFRICA IMMUNOTHERAPY DRUGS MARKET BY TYPE (THOUSAND UNITS) 2020-2029

TABLE 195 REST OF MIDDLE EAST AND AFRICA IMMUNOTHERAPY DRUGS MARKET BY THERAPY AREA (USD BILLION) 2020-2029

TABLE 196 REST OF MIDDLE EAST AND AFRICA IMMUNOTHERAPY DRUGS MARKET BY THERAPY AREA (THOUSAND UNITS) 2020-2029

TABLE 197 REST OF MIDDLE EAST AND AFRICA IMMUNOTHERAPY DRUGS MARKET BY END USER (USD BILLION) 2020-2029

TABLE 198 REST OF MIDDLE EAST AND AFRICA IMMUNOTHERAPY DRUGS MARKET BY END USER (THOUSAND UNITS) 2020-2029

LIST OF FIGURES

FIGURE 1 MARKET DYNAMICS

FIGURE 2 MARKET SEGMENTATION

FIGURE 3 REPORT TIMELINES: YEARS CONSIDERED

FIGURE 4 DATA TRIANGULATION

FIGURE 5 BOTTOM-UP APPROACH

FIGURE 6 TOP-DOWN APPROACH

FIGURE 7 RESEARCH FLOW

FIGURE 8 GLOBAL IMMUNOTHERAPY DRUGS MARKET BY TYPE, USD BILLION, 2020-2029

FIGURE 9 GLOBAL IMMUNOTHERAPY DRUGS MARKET BY THERAPY AREA, USD BILLION, 2020-2029

FIGURE 10 GLOBAL IMMUNOTHERAPY DRUGS MARKET BY END USER, USD BILLION, 2020-2029

FIGURE 11 GLOBAL IMMUNOTHERAPY DRUGS MARKET BY REGION, USD BILLION, 2020-2029

FIGURE 12 PORTER’S FIVE FORCES MODEL

FIGURE 13 GLOBAL IMMUNOTHERAPY DRUGS MARKET BY TYPE, USD BILLION, 2021

FIGURE 14 GLOBAL IMMUNOTHERAPY DRUGS MARKET BY THERAPY AREA, USD BILLION, 2021

FIGURE 15 GLOBAL IMMUNOTHERAPY DRUGS MARKET BY END USER, USD BILLION, 2021

FIGURE 16 GLOBAL IMMUNOTHERAPY DRUGS MARKET BY REGION, USD BILLION, 2021

FIGURE 17 NORTH AMERICA IMMUNOTHERAPY DRUGS MARKET SNAPSHOT

FIGURE 18 EUROPE IMMUNOTHERAPY DRUGS MARKET SNAPSHOT

FIGURE 19 SOUTH AMERICA IMMUNOTHERAPY DRUGS MARKET SNAPSHOT

FIGURE 20 ASIA PACIFIC IMMUNOTHERAPY DRUGS MARKET SNAPSHOT

FIGURE 21 MIDDLE EAST ASIA AND AFRICA IMMUNOTHERAPY DRUGS MARKET SNAPSHOT

FIGURE 22 MARKET SHARE ANALYSIS

FIGURE 23 AMGEN: COMPANY SNAPSHOT

FIGURE 24 NOVARTIS AG: COMPANY SNAPSHOT

FIGURE 25 ABBVIE INC.: COMPANY SNAPSHOT

FIGURE 26 PFIZER INC.: COMPANY SNAPSHOT

FIGURE 27 F. HOFFMAN-LA ROCHE LTD.: COMPANY SNAPSHOT

FIGURE 28 JOHNSON & JOHNSON SERVICES INC.: COMPANY SNAPSHOT

FIGURE 29 ASTAZENECA: COMPANY SNAPSHOT

FIGURE 30 GSK: COMPANY SNAPSHOT

FIGURE 31 SANOFI: COMPANY SNAPSHOT

FIGURE 32 BAYER AG: COMPANY SNAPSHOT